Dendreon (DNDN) yesterday confirmed that the SEC has opened an investigation, which could be...

|About: Dendreon Corporation (DNDN)|By:, SA News Editor

Dendreon (DNDN) yesterday confirmed that the SEC has opened an investigation, which could be connected to lawsuits accusing the company of misleading investors over Provenge. While Dendreon had initially been bullish about the prostate-cancer treatment, it shocked the market in August 2011 when it said that adoption was slow, causing Dendreon's stock to plunge over 65% in one day.